Total Payments
$4,060
2024 Payments
$171.22
Companies
31
Transactions
154
Medicare Patients
1,400
Medicare Billing
$171,752
Payment Breakdown by Category
Food & Beverage$3,215 (79.2%)
Travel$845.06 (20.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,215 | 150 | 79.2% |
| Travel and Lodging | $845.06 | 4 | 20.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nevro Corp. | $1,797 | 33 | $0 (2024) |
| Boston Scientific Corporation | $575.53 | 30 | $0 (2024) |
| Abbott Laboratories | $323.87 | 15 | $0 (2021) |
| Purdue Pharma L.P. | $155.39 | 9 | $0 (2018) |
| Scilex Pharmaceuticals Inc. | $125.21 | 6 | $0 (2023) |
| Amgen Inc. | $112.86 | 2 | $0 (2019) |
| Daiichi Sankyo Inc. | $104.66 | 6 | $0 (2018) |
| Collegium Pharmaceutical, Inc. | $89.37 | 6 | $0 (2021) |
| GRT US Holding, Inc. | $79.78 | 2 | $0 (2022) |
| INSYS Therapeutics Inc | $67.69 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $171.22 | 3 | Nevro Corp. ($104.86) |
| 2023 | $71.54 | 3 | Boston Scientific Corporation ($32.31) |
| 2022 | $95.14 | 3 | GRT US Holding, Inc. ($56.00) |
| 2021 | $146.74 | 8 | SCILEX PHARMACEUTICALS INC. ($65.88) |
| 2020 | $225.16 | 11 | Abbott Laboratories ($146.39) |
| 2019 | $238.42 | 13 | Boston Scientific Corporation ($54.15) |
| 2018 | $2,189 | 54 | Nevro Corp. ($1,408) |
| 2017 | $923.58 | 59 | Nevro Corp. ($283.74) |
All Payment Transactions
154 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 08/21/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $104.86 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/22/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $49.77 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/24/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Analgesic | ||||||
| 10/02/2023 | Azurity Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | Cash or cash equivalent | $19.04 | General |
| Category: Sleep | ||||||
| 09/19/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $32.31 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/08/2022 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Analgesic | ||||||
| 10/22/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $56.00 | General |
| Category: Pain Management | ||||||
| 08/01/2022 | Scilex Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $21.33 | General |
| 06/28/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Chronic Pain | ||||||
| 05/07/2021 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Analgesic | ||||||
| 03/31/2021 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: Analgesic | ||||||
| 03/04/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Neuromodulation | ||||||
| 02/25/2021 | IBSA Pharma Inc. | Licart (Drug) | Food and Beverage | Cash or cash equivalent | $22.30 | General |
| Category: non-opioid analgesic | ||||||
| 02/19/2021 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Analgesic | ||||||
| 02/16/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $11.10 | General |
| Category: Opioid Analgesic | ||||||
| 02/04/2021 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Pain Management | ||||||
| 11/11/2020 | BIODELIVERY SCIENCES INTERNATIONAL, INC. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Chronic Pain | ||||||
| 10/24/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 09/22/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 09/22/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $2.83 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 09/15/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 05/06/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 04/02/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $72.26 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 04/02/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 271 | 505 | $130,740 | $29,460 |
| 2022 | 8 | 215 | 745 | $120,718 | $24,178 |
| 2021 | 15 | 574 | 1,542 | $318,581 | $63,213 |
| 2020 | 14 | 340 | 1,015 | $404,583 | $54,901 |
Total Patients
1,400
Total Services
3,807
Medicare Billing
$171,752
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 147 | $66,150 | $11,117 | 16.8% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 30 | 31 | $23,250 | $7,501 | 32.3% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 28 | 34 | $11,900 | $3,813 | 32.0% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 14 | 14 | $6,580 | $2,148 | 32.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $6,380 | $1,202 | 18.8% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 17 | 17 | $3,230 | $1,035 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 15 | $4,800 | $987.29 | 20.6% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 14 | 22 | $4,840 | $937.96 | 19.4% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 38 | 49 | $1,960 | $592.80 | 30.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 27 | 165 | $1,650 | $124.58 | 7.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 65 | 116 | $39,228 | $8,870 | 22.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 16 | 25 | $37,485 | $5,741 | 15.3% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 13 | 16 | $16,030 | $2,862 | 17.9% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 20 | 25 | $6,800 | $2,833 | 41.7% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2022 | 23 | 38 | $6,950 | $1,641 | 23.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 14 | 25 | $8,485 | $1,557 | 18.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 53 | 480 | $4,800 | $424.52 | 8.8% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 11 | 20 | $940.00 | $248.86 | 26.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 98 | 151 | $26,274 | $14,562 | 55.4% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, single level | Office | 2021 | 25 | 39 | $52,500 | $9,388 | 17.9% |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | Office | 2021 | 28 | 41 | $43,050 | $8,327 | 19.3% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 49 | 61 | $12,200 | $6,980 | 57.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 66 | 86 | $14,964 | $5,721 | 38.2% |
| 64484 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, each additional level | Office | 2021 | 24 | 37 | $48,825 | $4,068 | 8.3% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance, single level | Office | 2021 | 11 | 16 | $24,150 | $3,045 | 12.6% |
About Dr. Susan Bertrand, MD
Dr. Susan Bertrand, MD is a Pain Medicine healthcare provider based in Cary, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1285627869.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Bertrand, MD has received a total of $4,060 in payments from pharmaceutical and medical device companies, with $171.22 received in 2024. These payments were reported across 154 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,215).
As a Medicare-enrolled provider, Bertrand has provided services to 1,400 Medicare beneficiaries, totaling 3,807 services with total Medicare billing of $171,752. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Pain Medicine
- Location Cary, NC
- Active Since 08/29/2005
- Last Updated 07/26/2021
- Taxonomy Code 208VP0000X
- Entity Type Individual
- NPI Number 1285627869
Products in Payments
- Senza Spinal Cord Stimulation System (Device) $1,692
- Proclaim Family of SCS IPGs (Device) $311.53
- GENERAL PAIN MANAGEMENT (Device) $168.23
- Aimovig (Biological) $112.86
- Senza (Device) $104.86
- ZTLido (Drug) $103.88
- WaveWriter Alpha Prime 16 (Device) $98.67
- Morphabond ER (Drug) $88.61
- SPECTRA WAVEWRITER (Device) $81.70
- SPECTRA SYSTEM (Device) $80.57
- Qutenza (Drug) $79.78
- GENERAL - THERAPIES (Device) $74.18
- SUBSYS (Drug) $67.69
- LYRICA (Drug) $59.55
- GENERAL - PAIN MANAGEMENT (Device) $49.79
- XTAMPZA (Drug) $47.90
- Nalocet (Drug) $46.50
- OXYCONTIN (Drug) $38.74
- Hymovis (Device) $37.96
- MOVANTIK (Drug) $35.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Cary
Zhicheng Li, Md, MD
Pain Medicine — Payments: $25,931
Pain Medicine $25,931
Brian Hertzberg, M.d, M.D
Pain Medicine — Payments: $13,128
Pain Medicine $13,128
Brian Wolf, Md, MD
Pain Medicine — Payments: $6,313
Pain Medicine $6,313
Dr. Chang Feng, Md, MD
Pain Medicine — Payments: $317.16
Pain Medicine $317.16